Nathan Osman

658 total citations
15 papers, 499 citations indexed

About

Nathan Osman is a scholar working on Infectious Diseases, Virology and Molecular Biology. According to data from OpenAlex, Nathan Osman has authored 15 papers receiving a total of 499 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 15 papers in Virology and 9 papers in Molecular Biology. Recurrent topics in Nathan Osman's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and Biochemical and Molecular Research (8 papers). Nathan Osman is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and Biochemical and Molecular Research (8 papers). Nathan Osman collaborates with scholars based in Canada, United States and Germany. Nathan Osman's co-authors include Mark A. Wainberg, Thibault Mésplède, Ying-Shan Han, Peter K. Quashie, Said Hassounah, Wei Huang, Diane N. Singhroy, Yolanda Lie, Hongtao Xu and Christos J. Petropoulos and has published in prestigious journals such as Journal of Virology, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Nathan Osman

15 papers receiving 496 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nathan Osman Canada 11 462 394 211 58 35 15 499
Said Hassounah Canada 12 405 0.9× 317 0.8× 172 0.8× 74 1.3× 105 3.0× 23 493
Olivia Goethals Belgium 10 276 0.6× 221 0.6× 126 0.6× 45 0.8× 72 2.1× 14 354
Marcia Van Ginderen Belgium 6 336 0.7× 284 0.7× 135 0.6× 109 1.9× 6 0.2× 6 387
Christel Van den Eynde Belgium 8 640 1.4× 592 1.5× 79 0.4× 126 2.2× 9 0.3× 13 764
Pascal Del-Giudice France 4 537 1.2× 499 1.3× 30 0.1× 72 1.2× 63 1.8× 4 621
Helen Scarnati United States 9 444 1.0× 434 1.1× 68 0.3× 56 1.0× 6 0.2× 12 518
Anne Derache France 15 435 0.9× 422 1.1× 68 0.3× 69 1.2× 6 0.2× 20 466
Yoeri Schrooten Belgium 12 309 0.7× 305 0.8× 58 0.3× 107 1.8× 11 0.3× 24 385
Fred Kyeyune Uganda 11 275 0.6× 275 0.7× 49 0.2× 47 0.8× 10 0.3× 16 321
Djeneba Fofana France 14 309 0.7× 264 0.7× 38 0.2× 111 1.9× 17 0.5× 35 420

Countries citing papers authored by Nathan Osman

Since Specialization
Citations

This map shows the geographic impact of Nathan Osman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Osman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Osman more than expected).

Fields of papers citing papers by Nathan Osman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Osman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Osman. The network helps show where Nathan Osman may publish in the future.

Co-authorship network of co-authors of Nathan Osman

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Osman. A scholar is included among the top collaborators of Nathan Osman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Osman. Nathan Osman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Brenner, Bluma, Ruxandra-Ilinca Ibanescu, Nathan Osman, et al.. (2021). The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002–2020). Viruses. 13(8). 1643–1643. 13 indexed citations
2.
White, Kirsten, Nathan Osman, Bluma Brenner, et al.. (2021). Long Dissociation of Bictegravir from HIV-1 Integrase-DNA Complexes. Antimicrobial Agents and Chemotherapy. 65(5). 25 indexed citations
3.
Osman, Nathan, Thibault Mésplède, Maureen Oliveira, et al.. (2018). Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout. AIDS. 32(13). 1773–1780. 1 indexed citations
4.
Palanisamy, Navaneethan, Nathan Osman, Hongtao Xu, et al.. (2017). Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study. AIDS Research and Therapy. 14(1). 2–2. 11 indexed citations
5.
Xu, Hongtao, Susan P. Colby-Germinario, Said Hassounah, et al.. (2017). Evaluation of Sofosbuvir (β-D-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine) as an inhibitor of Dengue virus replication #. Scientific Reports. 7(1). 6345–6345. 55 indexed citations
6.
Hassounah, Said, Ahmad Alikhani, Maureen Oliveira, et al.. (2017). Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1. Antimicrobial Agents and Chemotherapy. 61(12). 32 indexed citations
7.
Quashie, Peter K., Nathan Osman, Ying-Shan Han, et al.. (2015). Differential Effects of the G118R, H51Y, and E138K Resistance Substitutions in Different Subtypes of HIV Integrase. Journal of Virology. 89(6). 3163–3175. 64 indexed citations
8.
Osman, Nathan, Thibault Mésplède, Peter K. Quashie, et al.. (2015). Dolutegravir maintains a durable effect against HIV replication in tissue culture even after drug washout. Journal of Antimicrobial Chemotherapy. 70(10). 2810–2815. 6 indexed citations
9.
Mésplède, Thibault, Peter K. Quashie, Said Hassounah, et al.. (2015). The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B. AIDS. 29(12). 1459–1466. 15 indexed citations
11.
Mésplède, Thibault, Nathan Osman, Peter K. Quashie, et al.. (2014). Addition of E138K to R263K in HIV integrase increases resistance to dolutegravir, but fails to restore activity of the HIV integrase enzyme and viral replication capacity. Journal of Antimicrobial Chemotherapy. 69(10). 2733–2740. 39 indexed citations
12.
Quashie, Peter K., Thibault Mésplède, Ying-Shan Han, et al.. (2014). Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase. Antimicrobial Agents and Chemotherapy. 58(6). 3580–3580. 4 indexed citations
13.
Mésplède, Thibault, Peter K. Quashie, Nathan Osman, et al.. (2013). Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure. Retrovirology. 10(1). 22–22. 106 indexed citations
14.
Quashie, Peter K., Thibault Mésplède, Ying-Shan Han, et al.. (2013). Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase. Antimicrobial Agents and Chemotherapy. 58(1). 633–633. 2 indexed citations
15.
Quashie, Peter K., Thibault Mésplède, Ying-Shan Han, et al.. (2013). Biochemical Analysis of the Role of G118R-Linked Dolutegravir Drug Resistance Substitutions in HIV-1 Integrase. Antimicrobial Agents and Chemotherapy. 57(12). 6223–6235. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026